Scrutinizing enrollment in ALS clinical trials: room for improvement? - Wikidata - awgldk - TriplyDB

Scrutinizing enrollment in ALS clinical trials: room for improvement?

Scrutinizing enrollment in ALS clinical trials: room for improvement?

http://www.wikidata.org/entity/Q37209736

about

Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.Depression in amyotrophic lateral sclerosis.Adding more muscle and nerve to clinical trials.Peer recommendations on how to improve clinical research, and Conference wrap-up.ALSUntangled: introducing The Table of Evidence.SAPs: a different perspective.Modifiable barriers to enrollment in American ALS research studies.Modeling the course of amyotrophic lateral sclerosis.The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis ALSUntangled (ALSU): A Scientific Approach to Off-Label Treatment Options for People with ALS Using Tweets and Twitters IPLEX and the Telephone Game: The difficulty in separating myth from reality on the internet

P2860

Q26777929-94DE72A8-247D-4EBE-B7D5-9C0FE01AC419 Q30619235-3AD4995E-9FBB-4EDB-BDFD-1E58E0A0CC45 Q35163766-F143B0E0-5644-4D8F-9749-30CF55D99637 Q37946799-767A920E-F09A-41CB-A50F-6BEB1A11B400 Q38107221-612DAF33-0024-4F37-9058-9AA5538E93BB Q38302007-BDE12779-2E6F-442A-85E8-4A321D7C25C8 Q45107401-66E83402-8245-4E42-AC17-9813F7D96D03 Q45911812-5CF9FE4B-308F-45AA-9095-921A44DB2294 Q53648700-C6028714-0937-4081-A7FB-5B3BDC919855 Q56773744-0CF2034E-DB2A-4583-95A6-9C005E8545D9 Q58290709-41DE892B-FEB0-414E-9FC8-544046367D1B Q58307250-8B2B6DDD-A3D6-42A9-B0EA-CCD59866F10F

P2860

Scrutinizing enrollment in ALS clinical trials: room for improvement?

http://www.wikidata.org/entity/Q37209736

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Scrutinizing enrollment in ALS clinical trials: room for improvement?

@en

Scrutinizing enrollment in ALS clinical trials: room for improvement?

@nl

type

label

Scrutinizing enrollment in ALS clinical trials: room for improvement?

@en

Scrutinizing enrollment in ALS clinical trials: room for improvement?

@nl

prefLabel

Scrutinizing enrollment in ALS clinical trials: room for improvement?

@en

Scrutinizing enrollment in ALS clinical trials: room for improvement?

@nl

P1433

Q37209736-8FAB0CDB-DF19-445E-9602-074B3F0897EF

P1476

Q37209736-52FB5D29-6AC5-4667-9B8D-3A9912659BFD

P2093

Q37209736-0A8EEF2B-4557-4A29-912B-02EBB6916816

Q37209736-4FED0E5D-736D-4D17-B5D2-9B0A64F4AF45

Q37209736-684CF8A1-8E3B-4B59-BB9E-4B71F0B9ACC1

P2860

Q37209736-0EEE8582-84B6-4D33-8283-A9F3C33A8C7B

Q37209736-1C39D129-8994-4B02-8C79-82611F413CE4

Q37209736-3518706D-AC9F-4368-82F9-C5269C5B34AA

Q37209736-4A36A9F0-C895-48EA-8D5A-0E3923199D88

Q37209736-6751229E-FD37-4701-B1DF-664C24BF93D2

Q37209736-700BC3E5-E90D-486D-A7F1-466FA9FF9BE0

Q37209736-91C8BA1A-5FA4-441E-808C-47BB3053AC56

Q37209736-95EED375-125D-43BD-B540-E12F40EF450C

Q37209736-A58411C7-729C-4A64-95F9-FAC7D6C1B7BD

Q37209736-A773BAC8-2BA4-4F75-BCE1-B4CAF3D8C56C

P304

Q37209736-E0AD8D32-CDEE-4A73-98D4-103B7D66723B

P31

Q37209736-B7334972-11D4-4FB7-9AD6-AE211D6650A8

P356

Q37209736-29731814-E5A0-48B2-BD53-DB218C3071DB

P433

Q37209736-230437A8-9EE9-43EB-BBF6-AA6C78CF0F97

P478

Q37209736-8AE3B5EB-A2A3-4FA7-B9B1-B61BBF955A9D

P50

Q37209736-34091AB2-3957-44F8-BC15-A173F0F08C2F

Q37209736-3E0E883E-B363-44C2-B7CF-C6C0F2B530E6

P577

Q37209736-80ADFC9C-CBC8-4D0E-B572-FF0C30422427

P698

Q37209736-294B6F36-4BE2-4AB3-B12B-9E0765E1B548

P921

Q37209736-2A1B4173-DB32-4283-9CC7-04BEC0B1011D

P356

17482960802195913

P1433

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

P1476

Scrutinizing enrollment in ALS clinical trials: room for improvement?

@en

P2093

Darlene Pulley

http://www.w3.org/2001/XMLSchema#string

Emily Welsh

http://www.w3.org/2001/XMLSchema#string

Richard S Bedlack

http://www.w3.org/2001/XMLSchema#string

P2860

El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis

Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature.

Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

Biomarkers for amyotrophic lateral sclerosis.

Selecting promising ALS therapies in clinical trials.

Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis.

Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families?

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.

Participants in prospective, randomized clinical trials for resected non-small cell lung cancer have improved survival compared with nonparticipants in such trials.

A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis.

P304

257-265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17482960802195913

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Daniel M Pastula

Merit E Cudkowicz

P577

2008-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18608092

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis